# A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

> **NCT03936374** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BMS-986205
- **DRUG:** omeprazole

## Key facts

- **NCT ID:** NCT03936374
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-08
- **Primary completion:** 2019-07-20
- **Final completion:** 2019-07-20
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03936374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03936374, "A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03936374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*